Skip to main content

Table 3 Demographic data and OA history of the FAS population (N = 81)

From: Reduction of the Serum Levels of a Specific Biomarker of Cartilage Degradation (Coll2-1) by Hyaluronic Acid (KARTILAGE® CROSS) Compared to Placebo in Painful Knee Osteoarthritis Patients: the EPIKART Study, a Pilot Prospective Comparative Randomized Double Blind Trial

  IAHA
N = 40
Saline solution
N = 41
Total
N = 81
P value Test
Age (years) 66.9 ± 10.4 63.0 ± 8.9 65.0 ± 9.8 0.0752 Student
Sex      
 - Women
 - Men
62.5%
37.5%
75.6%
24.4%
69.1%
30.9%
0.2016 Chi-square test
BMI (kg/m2) 29.0 ± 7.4 30.8 ± 7.2 29.9 ± 7.3 0.2465 Student
Disease duration (year) 7.6 ± 8.0 5.9 ± 5.3 6.7 ± 6.8 0.2639 Student
Evaluated knee      
 - Right 45.0% 48.8% 46.9%   
 - Left 55.0% 51.2% 53.1% 0.7332 Chi-square test
Radiological score (K&L)      
 - Score II 52.5% 58.5% 55.6%   
 - Score III 47.5% 41.5% 44.4% 0.5846 Chi-square test
Night pain 52.5% 56.1% 54.3% 0.7452 Chi-square test
Effusion 20.0% 14.6% 17.3% 0.5231 Chi-square test
OA treatment for the past 3 months      
 - Acetomiphen 27.5% 41.5% 32.1% 0.2155 Chi-square test
 - NSAIDS 15.0% 12.2% 13.6% 0.7126 Chi-square test
 - slow acting anti OA drugs 7.5% 9.8% 8.6% 0.7179 Chi-square test